JumpCode Genomics, Inc.
Biotechnology company · San Diego, California, United States
JumpCode Genomics, Inc. is a biotechnology company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2016. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $383,748 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2024.
JumpCode Genomics at a glance
What does JumpCode Genomics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $383,748 in total (2025). NIH funding came from the National Human Genome Research Institute.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $3.5 million sold (2024).
Frequently asked questions about JumpCode Genomics
Where is JumpCode Genomics headquartered?
JumpCode Genomics, Inc. is headquartered in San Diego, California, United States.
What does JumpCode Genomics do?
JumpCode Genomics, Inc. is a biotechnology company.
When was JumpCode Genomics founded?
The earliest incorporation on record for JumpCode Genomics, Inc. is in 2016, according to public company registers.
Similar companies
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
- ImageneBio, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences